Impact Factor
3.35
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.54
179 total citations
h5-index
18
h5 depth signal
Cited share
83.9%
47 of 56
Total citations
179
Citation footprint
Metric signal
3.83
External metric anchor
Self-citation
0.6%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
106
United States
83
United Kingdom
73
Sweden
34
Japan
30
Citing Fields of Research
Diabetes
410
Cardiology
126
Vascular Disorders
42
Ophthalmology
32
Noncoding RNA
24
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,058
Articles tracked across the journal lifetime
Indexed publication set
56
47 cited publications
Last 12 months
45
7.5 publications/month
Open access share
100.0%
45 OA publications in the last year
Leading citing country
China
106 citing publications
Leading citing field
Diabetes
410 citing publications
Latest tracked publication
29 September 2026
10 recent records available
Coverage & Indexing History
v1n1, May 2004-
v1n1, May 2004-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Diabetes
Issuing & Sponsoring Bodies
Contributor
International Society of Diabetes and Vascular Disease
Broad Categories
Endocrinology
Vascular Diseases
Diabetes
Cardiology
Urology
Noncoding RNA
Obstetrics/Gynecology
Lipids
MeSH Descriptors
Cardiovascular Diseases
Diabetes Complications
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/14791641261495569
Open DOI
Benefits of sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide-1 receptor agonists in older patients with type 2 diabetes
Background: Type 2 diabetes mellitus (T2DM) increases the risk of cardiovascular and neurocognitive complications. GLP-1 receptor agonists (GLP-1 RAs) and SGLT2 inhibitors (SGLT2is) have pleiotropic effects beyond glycemic control, but c...
02
DOI 10.1177/14791641261493132
Open DOI
Carotid arterial stiffness is associated with selective glomerular hypofiltration of middle-sized molecules in type 2 diabetes
Background: Type 2 diabetes (T2D) is a major driver of premature vascular aging. We investigated whether Selective Glomerular Hypofiltration Syndromes (SGHS), expressed as ratios of cystatin C– or β2-microglobulin–based estimated glomeru...
03
DOI 10.1177/14791641261474039
Open DOI
Predominantly L-shaped association between hemoglobin glycation index and all-cause mortality in hospitalized patients with heart failure
Background: Heart failure (HF) is closely associated with abnormalities in glucose metabolism, which substantially influence clinical outcomes. The hemoglobin glycation index (HGI), reflecting the discrepancy between observed and predict...
04
DOI 10.1177/14791641261476326
Open DOI
Associations between inflammation and depressive symptoms in diabetes: A scoping review
Depression is a clinically important comorbidity in people living with diabetes, yet biological pathways linking these conditions remain unclear. Chronic inflammation has been proposed as one mechanism connecting metabolic dysfunction wi...
05
DOI 10.1177/14791641261484961
Open DOI
Circulating lysophosphatidylethanolamine species are associated with pericoronary adipose tissue inflammation and coronary atherosclerotic burden in type 2 diabetes
Background: Type 2 diabetes mellitus (T2DM) involves alterations in lipid metabolism beyond conventional cholesterol profiles. We examined whether specific plasma lipidomic signatures are related to pericoronary adipose tissue (PCAT) inf...
06
DOI 10.1177/14791641261487590
Open DOI
Impact of antidiabetic agents on COPD exacerbations in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis
Background: The impact of Antidiabetic Agents on COPD Exacerbations remains uncertain. We conducted a comprehensive review to evaluate the impact Antidiabetic Agents on COPD Exacerbations in patients with T2DM. Methods: We searched PubMe...
07
DOI 10.1177/14791641261474108
Open DOI
Association of domestic water hardness with incident diabetic retinopathy and the mediating role of GID8: A UK Biobank prospective cohort study
Purpose: To investigate the longitudinal association between domestic water hardness and incident diabetic retinopathy (DR) in individuals with type 2 diabetes (T2D) and identify circulating proteomic mediators. Methods: This study analy...
08
DOI 10.1177/14791641261474101
Open DOI
Relationship between non-O blood groups and microvascular risk in type 2 diabetes
Introduction: ABO groups impact macroangiopathy risk in T2D. It is unknown whether such modulation extends to microvascular complications. Method: Single-centre cross-sectional study including 1,006 T2D patients. Results: Prevalence of o...
09
DOI 10.1177/14791641251398558
Open DOI
Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus
Background: Advanced glycation end products (AGEs) can be measured non-invasively through skin autofluorescence (SAF). Studies on SAF in gestational diabetes mellitus (GDM) remain limited. This study aims to evaluate SAF in Tunisian preg...
10
DOI 10.1177/14791641261474034
Open DOI
Serum albumin-enhanced screening: A triage strategy and predictive model for OGTT in community-managed patients with coronary heart disease
Background: Patients with coronary heart disease (CHD) are at high risk of undiagnosed diabetes. Reliance on standard fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) may lead to underdiagnosis, highlighting the need for optimized...
Bibliographical & Catalog Notes
Description based on: Vol. 2, issue 1 (Feb. 2005); title from cover.
Also issued online.